← Leaderboards
Jenny E. Kanter
University Of Washington
$4,494,120
Attributed
$6,653,801
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,653,801 · 5
By mechanism
R01$5,328,878 · 2
P01$1,272,651 · 2
P30$52,272 · 1
Top collaborators
- Francis Kim4 shared
- Chun Yuan4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Chun Yuan$11,768,740
- Thomas Hatsukami$7,232,229
- Erik L Ritman$11,969,205
- Karin E. Bornfeldt$36,322,585
- Cecilia M. Giachelli$21,973,061
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsAtherosclerosisMacrophageDiabetes MellitusComplementLipoproteinsTriglyceridesCardiovascular DiseasesMyeloid CellsMouse ModelAffectTherapeutic TargetPreventIn VitroLipidsCause Of DeathPlasmaEndothelial CellsResidual StateInflammatoryArterial Fatty StreakCardiovascular Disorder RiskAccelerationHistologic
Grant awards (18)
Role of inflammation in intraplaque hemorrhage pathogenesis$812,944
R01 · FY2025 · HL
Core C: Atherosclerosis and bioinformatics core$301,110
P01 · FY2025 · HL · contact PI
Role of inflammation in intraplaque hemorrhage pathogenesis$798,845
R01 · FY2024 · HL
APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis$372,768
R01 · FY2024 · DK · contact PI
Core C: Myeloid cell and atherosclerosis core$203,139
P01 · FY2024 · HL · contact PI
Role of inflammation in intraplaque hemorrhage pathogenesis$807,682
R01 · FY2023 · HL
APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis$388,300
R01 · FY2023 · DK · contact PI
Core C: Myeloid cell and atherosclerosis core$188,723
P01 · FY2023 · HL · contact PI
APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis$98,037
R01 · FY2023 · DK · contact PI
Role of inflammation in intraplaque hemorrhage pathogenesis$820,050
R01 · FY2022 · HL
APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis$388,300
R01 · FY2022 · DK · contact PI
Core C: Myeloid cell and atherosclerosis core$188,210
P01 · FY2022 · HL · contact PI
APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis$65,352
R01 · FY2022 · DK · contact PI
APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis$388,300
R01 · FY2021 · DK · contact PI
Core C: Myeloid cell and atherosclerosis core$188,319
P01 · FY2021 · HL · contact PI
Enrichment Program$52,272
P30 · FY2021 · DK · contact PI
APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis$388,300
R01 · FY2020 · DK · contact PI
Core C: Myeloid cell and atherosclerosis core$203,150
P01 · FY2020 · HL · contact PI